Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Creative Medical Technology Holdings Inc CELZ

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201... see more

Current News (NDAQ:CELZ)

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

GlobeNewswire 5 days ago

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

GlobeNewswire 12 days ago

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

GlobeNewswire December 17, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of "olastrocel" as INN for Lead Allogeneic Cell Therapy CELZ-201

GlobeNewswire December 2, 2025

Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits

GlobeNewswire October 30, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds

GlobeNewswire October 29, 2025

Creative Medical Technology Holdings Issues Letter to Shareholders

GlobeNewswire October 27, 2025

Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs

GlobeNewswire October 7, 2025

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain

GlobeNewswire August 13, 2025

Opinion & Analysis (NDAQ:CELZ)

No current opinion is available.

Bullboard Posts (NDAQ:CELZ)

CELZ...a.m NR On watch

No position
Iseneschal - March 20, 2025

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ): A

http://beyondspx.com/2024/08/01/creative-medical-technology-holdings-inc-nasdaqcelz-a-promising-biotech-poised-for-breakthrough...
MikeTester - August 2, 2024

CELZ..... I see dead people

This will not turn out good
Iseneschal - March 7, 2024

CELZ......this is going to be interrogated ; )

Somebody knew something.....chart history tells me Lots of gaps to fill
Iseneschal - March 7, 2024

CELZ ....LoL....Scalp #1

Out at $9.70....Cha Ching
Iseneschal - March 7, 2024

CELZ .... LoL...been so busy with others

Haven't looked at this all morning ....seems as though it's been halted a few times
Iseneschal - February 8, 2023

Podcasts